IL17A and dementia: Combined with other studies that have demonstrated the association of propionate and IL-17 in modulating pathologies that contribute to dementia and other neuroimmune disorders (10–12), these findings support the potential utility of modifying the peripheral immune system to treat or prevent dementia and indicate that understanding an individual’s gut microbiota composition and function will be important in developing such strategies.